corner
Healthy Skepticism
Join us to help reduce harm from misleading health information.
Increase font size   Decrease font size   Print-friendly view   Print
Register Log in

Healthy Skepticism Library item: 7460

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

 

Publication type: news

Clark H.
The Most Charitable Industries
Forbes.com 2007 Jan 16
http://www.forbes.com/2007/01/16/leadership-philanthropy-charity-lead-citizen-cx_hc_0116charitable.html


Full text:

With their big philanthropic announcements last year, Microsoft’s Bill Gates and Berkshire Hathaway’s Warren Buffett may have been following a trend, not starting one. Companies and corporate foundations are becoming more charitable as well.

The Conference Board surveyed 211 of the largest companies and corporate foundations, and found that they gave $9.78 billion in 2005, up more than 18% from the previous year. Most of that money was spent in the U.S, with only $2 billion going overseas. More than half of all donations were products, rather than cash.

But that doesn’t necessarily mean companies have become more generous; they’re simply making more money. As a percentage of pretax income, companies in the survey actually gave less to American charities in 2005—1% of their U.S. earnings, compared with 1.6% the year before.

In Pictures: The Most Charitable Industries
Pharmaceutical companies, however, are far more generous than others. Perhaps because they’re fighting an increasingly negative public image, drug firms in the survey reported donating 13% of their U.S. income to American charities.

The global numbers give a slightly different picture, but drug firms still come out on top. Pharmaceutical companies donated 1.51% of their worldwide sales to charity; no other sector gave more than 1%, and many gave less than one-tenth of 1%.

Drug companies gave the most on a per-employee basis as well: $5,585. By contrast, the media and publishing industry, which came in second place, gave only $1,549 per worker, and the third-place petroleum sector donated only $818.

Nevertheless, more companies are giving, and companies are giving more. According to the survey, which will be released to the public on Wednesday, Jan. 17, the median gift increased to $12.52 million, up from $10.73 million in 2004.

The top priority for corporate givers was health care and human services, which accounted for 44% of all contributions. Education was a distant second, attracting 12% of the money. And arts, community and environmental organizations all received less than 10%.

 

  Healthy Skepticism on RSS   Healthy Skepticism on Facebook   Healthy Skepticism on Twitter

Please
Click to Register

(read more)

then
Click to Log in
for free access to more features of this website.

Forgot your username or password?

You are invited to
apply for membership
of Healthy Skepticism,
if you support our aims.

Pay a subscription

Support our work with a donation

Buy Healthy Skepticism T Shirts


If there is something you don't like, please tell us. If you like our work, please tell others.

Email a Friend








...to influence multinational corporations effectively, the efforts of governments will have to be complemented by others, notably the many voluntary organisations that have shown they can effectively represent society’s public-health interests…
A small group known as Healthy Skepticism; formerly the Medical Lobby for Appropriate Marketing) has consistently and insistently drawn the attention of producers to promotional malpractice, calling for (and often securing) correction. These organisations [Healthy Skepticism, Médecins Sans Frontières and Health Action International] are small, but they are capable; they bear malice towards no one, and they are inscrutably honest. If industry is indeed persuaded to face up to its social responsibilities in the coming years it may well be because of these associations and others like them.
- Dukes MN. Accountability of the pharmaceutical industry. Lancet. 2002 Nov 23; 360(9346)1682-4.